Harvard Bioscience (NASDAQ:HBIO) develops, manufactures and supplies specialized tools and equipment used in biological, medical and pharmaceutical research. Its products support applications including electrophysiology, cell and tissue research, drug discovery, organ and animal physiology, and laboratory data collection.
The company’s portfolio includes laboratory instruments, systems, consumables and software sold under brands such as Harvard Apparatus, DSI, BTX and Hugo Sachs Elektronik. These products include perfusion and organ-bath systems, stimulation and electroporation equipment, physiological monitoring devices, research sensors, and related laboratory supplies.
Founded in 1901, Harvard Bioscience serves academic institutions, government and research laboratories, biotechnology companies, pharmaceutical manufacturers and medical researchers. The company is headquartered in Holliston, Massachusetts, and distributes its products through direct sales and channel partners in North America, Europe, Asia and other international markets.
